SCHEMBL10248951

SCHEMBL10248951

FC1(F)CCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19588704 0.81
SCHEMBL10248882 0.79
Lithium SCHEMBL29736075 0.76
SCHEMBL25561206 0.69
SCHEMBL27335751 0.69
SCHEMBL12683477 0.69
SCHEMBL26577795 0.69
SCHEMBL25561207 0.69
SCHEMBL5945155 0.65
SCHEMBL25456015 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570666-B2 Furoindazole derivatives BAYER AKTIENGESELLSCHAFT (DE) 2026-03-10 US disclosed
US-20250070255-A1 LITHIUM SECONDARY BATTERY PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2025-02-27 US disclosed
EP-4443591-A1 LITHIUM SECONDARY BATTERY Panasonic Intellectual Property Management Co., Ltd. (JP) 2024-10-09 EP disclosed
CN-118435412-A Lithium secondary battery 松下知识产权经营株式会社 2024-08-02 CN disclosed
US-20240109930-A1 TRIAZOLYL-METHYL SUBSTITUTED ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2024-04-04 US disclosed
US-20230265057-A1 INHIBITORS OF PARG ARASE THERAPEUTICS INC. 2023-08-24 US disclosed
WO-2023100767-A1 LITHIUM SECONDARY BATTERY パナソニックIPマネジメント株式会社 2023-06-08 WO disclosed
US-20230112499-A1 FUROINDAZOLE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2023-04-13 US disclosed
US-20230028584-A1 ATF6 MODULATORS AND USES THEREOF ALTOS LABS, INC. 2023-01-26 US disclosed
EP-3475270-B1 HETEROARYL SUBSTITUTED AMINOPYRIDINE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2020-02-26 EP disclosed
US-9748572-B2 Ultrasound assisted in-situ formation of carbon/sulfur cathodes UCHICAGO ARGONNE, LLC (US) 2017-08-29 US disclosed
CN-105263941-A Alkyl esters of 2- { [ (2R,3S,5R) -5- (4-amino-2-oxo-2H-pyrimidin-1-yl) -3-hydroxy-tetrahydro-furan-2-ylmethoxy ] -phenoxy-phosphorylamino } -propionic acid, nucleoside inhibitors of HCV RNA-polymerase NS5B, processes for their preparation and their use IVACHTCHENKO ALEXANDRE VASILIEVICH 2016-01-20 CN disclosed
CN-104829671-A Gemcitabine/FTA/furazan conjugate in NO-donor type, preparation method and application UNIV NANTONG 2015-08-12 CN disclosed
CN-104693257-A Benzenesulfonyl furazan modified gemcitabine derivative and preparation method and use thereof UNIV NANTONG 2015-06-10 CN disclosed
US-20140255794-A1 SULFUR CATHODE HOSTED IN POROUS ORGANIC POLYMERIC MATRICES UCHICAGO ARGONNE LLC (US) 2014-09-11 US disclosed
US-8461181-B2 Fused heterocyclic compound and use thereof SUMITOMO CHEMICAL COMPANY, LTD. (JP) 2013-06-11 US disclosed
US-8273764-B2 Fused heterocyclic compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-09-25 US disclosed
US-20120178779-A1 FUSED HETEROCYCLIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED 2012-07-12 US disclosed
US-20120015975-A1 FUSED HETEROCYCLIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-01-19 US disclosed